Skip to Main Content

Paper Details

Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC).
Eur J Endocrinol
27
2017
Author NameAffiliation
Teresa Ram??n y CajalUniversity Hospital of Santa Creu i Sant Pau
  • 1 - 1

Datasets

Release 1.2